Over the last 12 months, Usana Health Sciences insiders reported no purchases and 7 sales totaling $544K across SEC Form 4 filings.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | Neidig BrentCHIEF COMMERCIAL OFFICER · O | ▼ Sale | 5,002 | $19.45 | $97K | -100% | — |
| Jun 15, 2026 | Neidig BrentCHIEF COMMERCIAL OFFICER · O | ▼ Sale | 2,511 | $20.1 | $50K | -33.4% | 2 tranches |
| Jun 8, 2026 | Jones Paul A.CHIEF PEOPLE OFFICER · O | ▼ Sale | 5,561 | $18.5 | $103K | -100% | — |
| Jun 1, 2026 | Fleming John TurmanD | ▼ Sale | 2,450 | $17.93 | $44K | -36.7% | — |
| May 28, 2026 | Jones Paul A.CHIEF PEOPLE OFFICER · O | ▼ Sale | 6,813 | $18.95 | $129K | -55.1% | — |
| May 27, 2026 | IIEKKING G DOUGCHIEF FINANCIAL OFFICER · O | ▼ Sale | 5,360 | $18.75 | $101K | -100% | — |
| May 22, 2026 | FULLER GILBERT AD | ▼ Sale | 1,057 | $18.66 | $20K | -100% | — |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $USNA feed.